Biliary scintigraphy with a new scanning agent, 99mTc-(SN)-pyridoxylidene-isoleucine.
99mTechnetium-pyridoxylidene-isoleucine (hereinafter referred to as 99mTc-PI) is a new biliary scintiscanning agent. It has been evaluated in both health volunteers and patients with known surgical biliary tract diseases. It results in imaging of the liver in three minutes and the common bile duct and duodenum in 10-20 minutes. Its advantages as a diagnostic tool in disease of the hepatobiliary systems are in reducing the amount of radiotracer required, in shortening examination time and in producing scintigrams of higher resolution.
D000293:Adolescent; D000328:Adult; D001659:Biliary Tract / Q000000981:diagnostic imaging*; D002769:Cholelithiasis / Q000000981:diagnostic imaging*; D002779:Cholestasis / Q000000981:diagnostic imaging*; D003135:Common Bile Duct / Q000000981:diagnostic imaging; D004386:Duodenum / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D007532:Isoleucine / Q000031:analogs & derivatives*; D008099:Liver / Q000000981:diagnostic imaging; D008297:Male; D015609:Organotechnetium Compounds; D011730:Pyridoxal / Q000031:analogs & derivatives*; D011877:Radionuclide Imaging; D013667:Technetium
D015609:Organotechnetium Compounds; C016707:technetium Tc 99m pyridoxylideneisoleucine; D007532:Isoleucine; D011730:Pyridoxal; D013667:Technetium